Nanobiotix S.A.
NBTX
$3.39
$0.24117.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -71.79% | -5.67% | 41.13% | 34.06% | 28.43% |
| Total Depreciation and Amortization | 7.05% | 7.03% | 7.36% | 6.58% | 3.35% |
| Total Amortization of Deferred Charges | 100.00% | 588.89% | -- | -- | -- |
| Total Other Non-Cash Items | 107.05% | 50.51% | -7.84% | -2.22% | 2.26% |
| Change in Net Operating Assets | 43.96% | 118.46% | 296.75% | 310.68% | 305.90% |
| Cash from Operations | -57.07% | 56.77% | 97.11% | 80.83% | 65.49% |
| Capital Expenditure | -158.21% | -103.04% | -47.43% | -95.45% | -255.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -417.54% | -305.48% | -131.93% | -115.92% | -109.35% |
| Cash from Investing | -173.96% | -149.27% | -111.27% | -677.01% | -361.69% |
| Total Debt Issued | -- | -100.00% | -100.00% | 0.00% | -- |
| Total Debt Repaid | -10.36% | -9.85% | -9.32% | 7.62% | 20.49% |
| Issuance of Common Stock | -- | 0.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 89.97% | -3.24% | -1,087.14% | -1,024.15% | -966.38% |
| Cash from Financing | -110.97% | -4.81% | 1,216.11% | 1,069.93% | 942.30% |
| Foreign Exchange rate Adjustments | 283.73% | 280.25% | 243.24% | -155.47% | -161.58% |
| Miscellaneous Cash Flow Adjustments | -- | 320.00% | 200.00% | 200.00% | -- |
| Net Change in Cash | -175.26% | 415.03% | 211.80% | 197.24% | 181.97% |